pharma SK Biopharmaceuticals LinX Platform: A Smart Move for Biotech November 9, 2026 Vincent Hughes SK Biopharmaceuticals LinX platform offers support to 31 Korean biotech firms, enhancing innovation and collaboration.
pharma Methylprednisolone Injection approval: Best News for Gland Pharma November 4, 2026 Vincent Hughes Methylprednisolone Injection approval is a significant milestone for Gland Pharma, securing USFDA endorsement.
Business Expansion Ascentium acquisitions India: Smart Growth Strategy Ahead November 2, 2026 Vincent Hughes Ascentium acquisitions India are set to drive growth in the market, expanding their influence and capabilities in the region.
Health Use the Medicine Label to Search Canada’s Drug Product Database October 31, 2026 Vincent Hughes To look up a proposed injectable medicine in Health Canada’s Drug Product Database, start with the actual product label. Use its drug identification number, or search with the exact product…
pharma Are Cancer Drug Price Cuts the Worst for Patients? October 30, 2026 Vincent Hughes Cancer drug price cuts fail to deliver real benefits to patients using expensive brands.
Pharmaceuticals Valganciclovir oral solution: Proven Safe Treatment for Patients October 27, 2026 Vincent Hughes Valganciclovir oral solution offers a proven safe treatment option for patients needing antiviral therapy.
pharma FDA Accelerated Approval: Is Ultomiris the Best Option? October 22, 2026 Vincent Hughes FDA accelerated approval has been granted to Ultomiris for IgAN treatment, offering new hope for patients.
healthcare Cancer Treatment Costs India: What Are the Real Solutions? October 19, 2026 Vincent Hughes Cancer treatment costs India are rising. Can Article 21 provide effective price regulation?
pharma FDA Approval for Liver Cancer Drug: Clear Path Ahead October 15, 2026 Vincent Hughes FDA approval liver cancer drug is anticipated this year as HLB resolves manufacturing issues.
Pharmaceuticals Price Caps on Life-Saving Drugs: A Smart Step Forward October 10, 2026 Vincent Hughes Price caps on life-saving drugs are crucial for patient access and affordability.